EN DE
Watch Hubei Xingfa Chemicals Group Co Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Hubei Xingfa Chemicals Group Co Ltd (600141) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Hubei Xingfa Chemicals Group Co Ltd stock ¥21.21, price ¥23.69, that is 10.5% below the price, quality 48 out of 100. Rating: overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials CN · ISIN CNE000000ZC9

HX Hubei Xingfa Chemicals Group Co Ltd logo Some data Nov 2, 2026

Hubei Xingfa Chemicals Group Co Ltd

600141 · SHG
Expensive, weak quality

Our calculation puts a fair price 10% below what the stock costs today.

Low debt
Ranks above peers (9/14)
Last quarter vs. a year ago: revenue +35%, profit +31%.
Quality 48/100
Expensive Growth (revenue 5y +9.8 %/yr in CNY)
Thin margins · 5.0% net margin (TTM)
3.0% dividend yield · Watch coverage
Some data
Fair value ¥21.21 · Overvalued (−10.5%)
Negative free cash flow
Narrow moat 36/100 · thin data
⟳ Cyclical
Watch Hubei Xingfa Chemicals Group Co Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

¥52.34 ¥15.05 Fair Value ¥21.21 May 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 2, 2026.

How to read this chart

60‑month range ¥15.05 – ¥52.34 · fair‑value band ¥15.90 – ¥28.53 · the ¥23.69 price screens above the ¥21.21 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 2, 2026.

Follow Hubei Xingfa Chemicals Group Co in your weekly email

Every Wednesday you see whether Hubei Xingfa Chemicals Group Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Hubei Xingfa Chemicals Group Co., Ltd., together with its subsidiaries, develops, produces, and sells phosphorus-based chemicals in China and internationally.

Show moreShow less

The company offers phosphoric products, such as phosphoric acid; sodium hexametaphosphate, tripolyphosphate, hypophosphite, monofluorophosphate, trimetaphosphate, and acid pyrophosphate; trisodium phosphate and disodium phosphate food grade; dicalcium, monosodium, dipotassium, tricalcium, and triethyl phosphate; tetrapotassium pyrophosphate, tetrasodium pyrophosphate, and trisodium acid pyrophosphate; tetrakis hydroxymethyl phosphonium sulfate, tetrakis hydroxymethyl phosphonium sulfate-urea, tetrakis hydroxymethyl phosphonium chloride, and tetrakis hydroxymethyl phosphonium chloride-urea; and tris(1-chloro-2-propyl) phosphate and tris(hydroxymethyl) phosphine oxide.

It also provides compound food additives; herbicides; organic silicones; fertilizers comprising monoammonium, diammonium phosphate, calcium hypophosphite monohydrate, and compound fertilizer; and electronic chemicals, including phosphoric and sulfuric acids EL grade, etchant, stripper, developer, and dimethyl sulfoxide.

In addition, the company offers basic chemicals comprising glycine, calcium and sodium hypochlorite, anhydrous calcium chloride, phosphoric acid, yellow phosphorus, methylal, methyl chloride, phosphorus oxychloride, phosphorus trichloride, sodium hydroxide, calcium chloride dihydrate, liquid chlorine, hydrochloric acid, phosphate rocks, phosphorous acid, sodium fluorosilicate, ferrophosphorus, dimethyl dichlorosilance.

Further, it provides vulcanization products, including dimethyl sulfoxide, dimethyl sulfone, dimethyl disulfide, dimethyl sulfide, sodium methyl mercaptide. ethyl mercaptan, t-dodecyl mercaptan, and phosphorus pentasulphide; and lithium iron phosphate and iron phosphate.

Hubei Xingfa Chemicals Group Co., Ltd. was founded in 1984 and is based in Yichang, China.

Stock analysis

Hubei Xingfa Chemicals Group Co Ltd (600141) currently trades at ¥23.69, while our model-based Fair Value estimate is ¥21.21, 10% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ¥26.16 per share, and 3 of the 16 models we run sit above the ¥23.69 price.

Bear case: the Asset-Based group reads lowest at ¥9.62, and 13 of the 16 models stay below the price. Data coverage for this calculation is medium.

Scenario range: ¥15.90 (bear) to ¥28.53 (bull), the price of ¥23.69 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 48/100 (below-average quality), in the Basic Materials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Hubei Xingfa Chemicals Group Co Ltd reported revenue of 29.3B CNY in FY2025 versus 23.9B CNY in FY2021, a compound +5.2%/yr. Reported net income was 1.5B CNY in FY2025, compounding −23.2%/yr from FY2021.

Key figures

Market cap 27.7B CNY (≈ $4.1B) Mid · P/E ratio 17.2 · P/S ratio 0.86 · EPS (TTM) ¥1.38 · Dividend yield 3.0% · Net margin 5.0% · Return on equity 7.1% · Return on assets (EBIT) 10.2% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 36 out of 100 (low confidence).

What moves the price

The share trades about 51% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −25% fair-value upside, at −10%, 600141 screens cheaper than that median.

Fair Value models

Bear ¥15.90 Fair Value ¥21.21 Bull ¥28.53
Price ¥23.69 · Downside -10.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.5813 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income ¥14.67 ¥15.38 ¥16.67 76
EPV ¥9.64 ¥12.22 ¥14.44 74
ROIC Compounder ¥9.64 ¥12.22 ¥14.44 72
All 16 models by family
Earnings-Based
Graham-Dodd ¥8.48 ¥48.10 ¥66.85 63
Lynch FV ¥13.51 ¥19.30 ¥25.09 61
PEG = 1.0 ¥13.51 ¥19.30 ¥25.09 57
EPV ¥9.64 ¥12.22 ¥14.44 74
Dividend Discount
Gordon GGM ¥11.31 ¥22.17 ¥33.01 67
DDM Multi-Stage ¥11.31 ¥19.34 ¥23.46 67
Multiples
P/E Multiple ¥15.90 ¥21.21 ¥26.51 63
P/S Multiple ¥15.90 ¥21.21 ¥26.51 58
P/B Multiple ¥16.19 ¥21.58 ¥26.98 55
EV/EBIT ¥14.04 ¥21.96 ¥29.89 65
EV/EBITDA ¥24.73 ¥36.23 ¥47.72 67
EV/Revenue ¥10.87 ¥19.70 ¥28.53 52
Asset-Based
NCAV (Graham) ¥7.18 ¥9.62 ¥14.36 54
Economic Profit
Residual Income ¥14.67 ¥15.38 ¥16.67 76
ROIC Compounder ¥9.64 ¥12.22 ¥14.44 72
Growth Earnings
Growth-Adj P/E ¥18.31 ¥26.16 ¥34.01 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 48/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 30
How much profit the company makes from its sales and capital
Quality Growth 39
Are margins and returns getting better?
Cashflow 20
Do the profits arrive as real cash?
Financial strength 42
Debt, balance sheet and risk of trouble
Investment 72
Does it invest with discipline instead of growing at any price?
Low Volatility 47
How calm the share price moves, does not count
Price momentum 22
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 14
Distance to the 52-week high, does not count
New shares 95
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 48/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+3.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.8%
Start year 2020 (pandemic). Over 10 years: +9.0% a year
Revenue growth 29 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.9%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+20.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year+17.6%
Dividend (yield on the price)3.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.base effect: 17.6% / 25.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 9%
Pace: the 5-year rate starts in 2020 (pandemic)

600141 screens overvalued: fair value 10% below the price. Compare with BASF SE →

Compare Hubei Xingfa Chemicals Group Co Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 336 stocks

Beats the industry median on 9/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 48 · Below median
Fair Value upside −10.5% · Above median
Profitability
Return on equity (12 months) 7.1% · Above median
Return on assets 2.9% · Below median
Net margin (12 months) 5.0% · Below median
Operating margin (12 months) 9.8% · Above median
Growth and dividend
Revenue growth (quarter YoY) 35.3% · Top 25%
Dividend yield (12 months) 3.0% · Above median
Balance sheet
Debt / equity 0.47× · Highest 25%

Valuation Multiplesvs Chemicals median · lower = cheaper

P/E (12 months) 17.2× · Cheaper than median
P/B 1.26× · Cheaper than median
P/S (12 months) 0.86× · Cheaper than median
EV/EBITDA 6.6× · Cheaper than median
PEG 1.05× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)19 · sector 8
FUTURE (revenue growth)100 · sector 69
PAST (return on equity)29 · sector 24
HEALTH (low debt)77 · sector 94
DIVIDEND (yield)59 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
LG Chem, Ltd 051910 232,000 KRW 587,755 KRW +153% vs 600141
Dow Inc DOW $31.40 $41.88 +33% vs 600141
Hengli Petrochemical Co 600346 ¥16.62 ¥19.26 +16% vs 600141
Ningxia Baofeng Energy Group 600989 ¥21.24 ¥22.31 +5% vs 600141
Saudi Basic Industries Corporation 2010 48.06 SAR 36.26 SAR −25% vs 600141
BASF SE BAS €54.28 €38.46 −29% vs 600141
Jiangsu Eastern Shenghong Co 000301 ¥10.41 ¥6.28 −40% vs 600141
Zhejiang Juhua Co 600160 ¥32.32 ¥19.31 −40% vs 600141
Formosa Chemicals & Fibre Corporation 1326 62.70 TWD 35.56 TWD −43% vs 600141
Zangge Mining Company 000408 ¥66.38 ¥17.47 −74% vs 600141

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Hubei Xingfa Chemicals Group Co Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Hubei Xingfa Chemicals Group Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/600141

Frequently asked questions

Is Hubei Xingfa Chemicals Group Co Ltd (600141) overvalued or undervalued?
As of Nov 2, 2026, our model estimates a fair value of ¥21.21 versus a price of ¥23.69, about 10% lower (overvalued).
What is the fair value of 600141?
Our model-based fair value for Hubei Xingfa Chemicals Group Co Ltd is ¥21.21 (as of Nov 2, 2026), built from audited fundamentals. The current price: ¥23.69.
What is the quality score of 600141?
Hubei Xingfa Chemicals Group Co Ltd has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Hubei Xingfa Chemicals Group Co Ltd (600141)?
Our model-based price target is the fair value of ¥21.21 (as of Nov 2, 2026) from 16 valuation models. Cautious scenario ¥15.90, optimistic scenario ¥28.53. It is a calculation from audited fundamentals, not an analyst target.
What is the Hubei Xingfa Chemicals Group Co Ltd stock forecast for 2026?
Our models put fair value at ¥21.21, about 10% lower versus a price of ¥23.69 (overvalued). Cautious scenario ¥15.90, optimistic scenario ¥28.53. The calculation is refreshed regularly with new filings.
What is the revenue of Hubei Xingfa Chemicals Group Co Ltd (600141)?
Hubei Xingfa Chemicals Group Co Ltd reported trailing-twelve-month revenue of about 32.1B CNY (latest available figure, as of Nov 2, 2026).
Does Hubei Xingfa Chemicals Group Co Ltd pay a dividend?
Hubei Xingfa Chemicals Group Co Ltd currently shows a dividend yield of 2.95% relative to its recent price (as of Nov 2, 2026).
How much is the dividend of Hubei Xingfa Chemicals Group Co Ltd (600141) and when is the ex-dividend date?
Hubei Xingfa Chemicals Group Co Ltd pays a dividend of ¥0.7 per share a year, a dividend yield of 3.0%. The last ex-dividend date was Jun 22, 2026. The payout ratio is 50.7% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Hubei Xingfa Chemicals Group Co Ltd (600141)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Hubei Xingfa Chemicals Group Co Ltd it is ¥21.21 per share (as of Nov 2, 2026), against a price of ¥23.69. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Hubei Xingfa Chemicals Group Co Ltd stock overvalued or undervalued in 2026?
As of Nov 2, 2026, 600141 trades above its calculated fair value: price ¥23.69, fair value ¥21.21, a gap of about −10% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 600141?
No. The price is what the market pays today (¥23.69); the fair value is what the company's own numbers justify (¥21.21). For Hubei Xingfa Chemicals Group Co Ltd the two are ¥2.48 per share apart. That gap is exactly why we show both numbers side by side.
How much is Hubei Xingfa Chemicals Group Co Ltd worth?
The market values Hubei Xingfa Chemicals Group Co Ltd at about 27.7B CNY (market capitalisation, as of Nov 2, 2026). Per share that is ¥23.69; our models calculate a fair value of ¥21.21 per share.
What do the bullish and bearish scenarios say about 600141?
Our models span a range for Hubei Xingfa Chemicals Group Co Ltd: cautious scenario ¥15.90, base ¥21.21, optimistic ¥28.53 per share (as of Nov 2, 2026, price ¥23.69). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 600141?
Hubei Xingfa Chemicals Group Co Ltd trades at a price-to-earnings ratio of 17.2 (as of Nov 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥21.21 is built from several models across several years. Median P/E at fiscal year-end, 8 fiscal years (2018 to 2025), reported earnings, FY2025 ex one-offs: 16.9. Other multiples: PEG 1.1, P/B 1.3, P/S 0.9, EV/EBITDA 6.6.
What is the PEG ratio of 600141?
The PEG ratio of Hubei Xingfa Chemicals Group Co Ltd is 1.05 (P/E divided by earnings growth, as of Nov 2, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Hubei Xingfa Chemicals Group Co Ltd (600141)?
Balance-sheet figures for Hubei Xingfa Chemicals Group Co Ltd (as of Nov 2, 2026): return on equity 7.1%, debt of 0.47 per unit of equity. They feed the Quality Score of 48/100, which measures business quality independently of the share price.
How far is 600141 from its 52-week high?
Hubei Xingfa Chemicals Group Co Ltd trades at ¥23.69, about 51% below its 52-week high of ¥48.80 and 7% above the low of ¥22.09 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ¥21.21 is for.
Which stocks are comparable to Hubei Xingfa Chemicals Group Co Ltd?
From the same area (Basic Materials) we also value BASF SE, Saudi Basic Industries Corporation, Dow Inc, Ningxia Baofeng Energy Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Hubei Xingfa Chemicals Group Co Ltd stock attractive at the current price?
The data as of Nov 2, 2026: price ¥23.69, calculated fair value ¥21.21 (−10%), Quality Score 48/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 600141 calculated?
We run Hubei Xingfa Chemicals Group Co Ltd through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥21.21 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Hubei Xingfa Chemicals Group Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Hubei Xingfa Chemicals Group Co Ltd (600141)?
The closing price on Nov 6, 2026 was ¥23.69. Our model-based fair value is ¥21.21, about 10% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Hubei Xingfa Chemicals Group Co Ltd right now?
The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Where does the earnings growth of Hubei Xingfa Chemicals Group Co Ltd (600141) come from?
Earnings per share at Hubei Xingfa Chemicals Group Co Ltd grew +24.2 % a year from 2013 to 2024. Broken into its drivers: revenue per share +2.6 %, EBIT margin +22.0 %, tax rate +0.7 %, residual (interest, one-offs) −1.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Hubei Xingfa Chemicals Group Co Ltd

How large is the market capitalisation of Hubei Xingfa Chemicals Group Co Ltd (600141)?
The market capitalisation of Hubei Xingfa Chemicals Group Co Ltd is 27.7B CNY (≈ $4.1B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Hubei Xingfa Chemicals Group Co Ltd (600141)?
The price-to-sales ratio of Hubei Xingfa Chemicals Group Co Ltd is 0.86 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Hubei Xingfa Chemicals Group Co Ltd (600141)?
Earnings per share at Hubei Xingfa Chemicals Group Co Ltd are ¥1.38 (price ÷ EPS = P/E 17.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Hubei Xingfa Chemicals Group Co Ltd (600141)?
The dividend yield of Hubei Xingfa Chemicals Group Co Ltd is 3.0% (payout 50.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Hubei Xingfa Chemicals Group Co Ltd (600141)?
The net margin of Hubei Xingfa Chemicals Group Co Ltd is 5.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Hubei Xingfa Chemicals Group Co Ltd (600141)?
The return on equity (ROE) of Hubei Xingfa Chemicals Group Co Ltd is 7.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Hubei Xingfa Chemicals Group Co Ltd (600141)?
On an EBIT basis the return on assets of Hubei Xingfa Chemicals Group Co Ltd is 10.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Hubei Xingfa Chemicals Group Co Ltd (600141)?
The operating margin of Hubei Xingfa Chemicals Group Co Ltd is 9.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Hubei Xingfa Chemicals Group Co Ltd (600141)?
Revenue at Hubei Xingfa Chemicals Group Co Ltd is growing +35.3% versus a year earlier (3y avg −1.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Hubei Xingfa Chemicals Group Co Ltd (600141)?
Earnings per share at Hubei Xingfa Chemicals Group Co Ltd are growing +31.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Hubei Xingfa Chemicals Group Co Ltd (600141) generate?
The free cash flow of Hubei Xingfa Chemicals Group Co Ltd is −634M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Hubei Xingfa Chemicals Group Co Ltd (600141) carry?
The net debt of Hubei Xingfa Chemicals Group Co Ltd is 11.6B CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Hubei Xingfa Chemicals Group Co Ltd in the live analysis

One click puts Hubei Xingfa Chemicals Group Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.